Ferroptosis in salivary gland disorders: mechanisms, biomarkers, and therapeutic perspectives
Apoptosis · 2026-02 · 31 (2)
DOI: 10.1007/s10495-026-02285-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Apoptosis, online erschienen am 09.02.2026. Verfasst von Jaewang Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-do, 13496, Republic of Korea. Hauptthemen laut MEDLINE: Ferroptosis, Salivary Gland Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, has been increasingly recognized as a key mechanism in salivary gland disorders. Initially identified in postmenopausal xerostomia, evidence now extends to autoimmune diseases, radiation-induced injury, hormonal regulation, and malignant tumors such as adenoid cystic carcinoma. Rather than being a secondary consequence of oxidative stress, ferroptosis actively contributes to epithelial damage, inflammatory amplification, and resistance to therapy. In Sjögren’s disease, interferon-γ promotes ferroptotic death of salivary epithelial cells through suppression of antioxidant defenses. Radiation accelerates ferritinophagy, iron release, and GPX4 loss, driving acinar injury that can be alleviated by radioprotective agents. Estrogen deficiency enhances ferroptosis via altered iron handling and hormone receptor signaling, while pharmacological inhibitors and natural compounds restore salivary function in experimental models. In malignant salivary tumors, inhibition of NOTCH1 or the use of iron-based nanomedicine induces ferroptosis and overcomes apoptosis resistance, highlighting its therapeutic promise. Beyond treatment, saliva and exosomal cargo have emerged as non-invasive sources of ferroptosis-related biomarkers, offering opportunities for disease monitoring and patient stratification. Despite these advances, challenges remain in validating biomarkers, characterizing alternative defense systems, and translating preclinical insights into clinical trials. Collectively, current findings position ferroptosis as both a mechanistic driver and a tractable therapeutic target in salivary gland biology, with broad implications for precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-do, 13496, Republic of Korea.
- Logsynk, Seoul, Republic of Korea.
- Department of Otorhinolaryngology-Head and Neck Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-do, 13496, Republic of Korea. rohjl@cha.ac.kr.
- Department of Biomedical Science, General Graduate School, CHA University, Pocheon, Republic of Korea. rohjl@cha.ac.kr.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Lee, J., & Roh, J. L. (2026). Ferroptosis in salivary gland disorders: mechanisms, biomarkers, and therapeutic perspectives. Apoptosis, 31(2). https://doi.org/10.1007/s10495-026-02285-3
Vancouver
Lee J, Roh JL. Ferroptosis in salivary gland disorders: mechanisms, biomarkers, and therapeutic perspectives. Apoptosis. 2026;31(2). doi:10.1007/s10495-026-02285-3
BibTeX
@article{Lee2026,
author = {Lee, Jaewang and Roh, Jong-Lyel},
title = {Ferroptosis in salivary gland disorders: mechanisms, biomarkers, and therapeutic perspectives},
journal = {Apoptosis},
year = {2026},
volume = {31},
number = {2},
doi = {10.1007/s10495-026-02285-3}
}
EUVIMED